📰 Contract Development News
Page 12 - Contract Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Development. Real-time updates on events, politics, business and more.
February 16, 2024
16.02.2024 - Sharps and Roncadelle are Joining Forces to Supply Drug Delivery Systems to the International HealthCare Market Through an Expanded Network of North American 3PL Distribution PartnershipsNEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) - Sharps ... Seite 1
February 15, 2024
TrophiCell specialises in developing novel adult stem cell-based therapies
February 14, 2024
Vetter, a leading globally operating contract development and manufacturing organization (CDMO) announces the successful commercialization of eight customer drug products as of the completion of 2023. The products were supported by the comprehensive...
February 14, 2024
Portfolio of early- and late-stage clinical services advances product development for injectablesVetter successfully brought eight customer drugs to market after supporting them through the development phasesAs an established leader in commercial fill and finish, Vetter has evolved as a trusted provider of drug prod...
February 13, 2024
/PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co."), the Japan-based multinational corporation covering food, healthcare and electronic materials, and built...
February 9, 2024
TECNALIA makes the identification of genetic and specific biomarkers for early diagnoses available to clinics and oncology professionals.
February 1, 2024
Genflow Biosciences Plc LONDON, Feb. 01, 2024 -- The Company , an emerging leader in the field of longevity research developing therapeutics that potentially halt or slow the ageing...
January 30, 2024
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
January 30, 2024
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and...
January 30, 2024
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and...